SRG
CVS icon

SBB Research Group’s CVS Health CVS Stock Holding History

SBB Research Group’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		$718K Buy
10,281
+81
+0.8% +$5.74K 1.28% 15
2023
Q2 		$705K Buy
10,200
+83
+0.8% +$5.91K 1.28% 16
2023
Q1 		$752K Buy
10,117
+68
+0.7% +$5.7K 1.06% 18
2022
Q4 		$936K Buy
10,049
+57
+0.6% +$5.5K 1.35% 12
2022
Q3 		$953K Buy
9,992
+56
+0.6% +$5.54K 1.35% 12
2022
Q2 		$921K Buy
9,936
+53
+0.5% +$5.17K 0.37% 19
2022
Q1 		$1M Sell
9,883
-551
-5% -$57.9K 0.22% 19
2021
Q4 		$1.08M Buy
+10,434
New +$964K 0.16% 19

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

SBB Research Group's CVS Position: Q3 2023 in Review

SBB Research Group increased its CVS Health (CVS) stake by 0.79% in Q3 2023, buying an estimated $5.74K and bringing the position to 10,281 shares worth $718K. The position accounts for 1.28% of the portfolio, ranked #15.

SBB Research Group first reported a position in CVS in Q4 2021 and has held it in 8 quarters since. The position peaked at $1.08M in Q4 2021. 2,114 funds tracked by Wall St. Rank hold CVS as of Q3 2023.

  • SBB Research Group held 10,281 shares of CVS Health worth $718K as of Q3 2023.
  • SBB Research Group bought 81 CVS Health shares in Q3 2023, an estimated $5.74K.
  • CVS Health made up 1.28% of SBB Research Group's portfolio in Q3 2023, its #15 holding.
  • SBB Research Group first reported a position in CVS Health in Q4 2021 and has held it in 8 quarters since.
  • SBB Research Group's CVS Health position peaked at $1.08M in Q4 2021.
  • 2,114 funds tracked by Wall St. Rank held CVS Health as of Q3 2023.

Based on SBB Research Group's 13F filing for Q3 2023, filed 13 Nov 2023.